CERE Cerevel Therapeutics Holdings Inc

USD 42.55 -0.04 -0.093919
Icon

Cerevel Therapeutics Holdings Inc (CERE) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 42.55

-0.04 (-0.09)%

USD 7.60B

0.91M

USD 42.50(-0.12%)

USD 0.00 (-100.00%)

Icon

CERE

Cerevel Therapeutics Holdings Inc (USD)
COMMON STOCK | NSD
USD 42.55
0.00 0
Take a Tour

Cerevel Therapeutics Holdings Inc (CERE) Stock Forecast

Show ratings and price targets of :
USD 42.50
(-0.12%)

Based on the Cerevel Therapeutics Holdings Inc stock forecast from 7 analysts, the average analyst target price for Cerevel Therapeutics Holdings Inc is USD 42.50 over the next 12 months. Cerevel Therapeutics Holdings Inc’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Cerevel Therapeutics Holdings Inc is Slightly Bearish, which is based on 2 positive signals and 4 negative signals. At the last closing, Cerevel Therapeutics Holdings Inc’s stock price was USD 42.55. Cerevel Therapeutics Holdings Inc’s stock price has changed by +0.19% over the past week, +0.52% over the past month and +33.30% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...